Beijing Chunli Zhengda Medical Instrument Co., Ltd
Initial public offering and listing on the science and Innovation Board
Announcement of issuance results
Sponsor (lead underwriter):
hot tip
The application of Beijing Chunli Zhengda medical device Co., Ltd. (hereinafter referred to as "Chunli medical", "issuer" or "company") for initial public offering of RMB common shares (A shares) and listing on the science and Innovation Board (hereinafter referred to as "this offering") has been examined and approved by the stock listing committee of the science and Innovation Board of Shanghai Stock Exchange and has been approved by the China Securities Regulatory Commission (hereinafter referred to as "CSRC") agrees to register (zjxk [2021] No. 3702). The sponsor and lead underwriter of this offering are Huatai United Securities Co., Ltd. (hereinafter referred to as "Huatai United Securities" or "sponsor (lead underwriter)"). The issuer's shares are referred to as "Chunli medical" and the expansion is referred to as "Chunli Zhengda medical" , stock code 688236.
This issuance adopts directional placement to strategic investors (hereinafter referred to as "strategic placement"), offline inquiry placement to qualified offline investors (hereinafter referred to as "offline issuance") and online pricing issuance to social public investors holding the market value of non restricted A-Shares and non restricted depositary receipts in Shanghai market (hereinafter referred to as "online issuance") ）Combined.
Issuer and sponsor (lead underwriter) comprehensively considering the issuer's fundamentals, the number of shares issued in this public offering, the issuer's industry, the valuation level of comparable listed companies, market conditions, demand for raised funds and underwriting risks, it is negotiated and determined that the issue price is 29.81 yuan / share, and the issue number is 38.428 million shares, all of which are new shares without transfer of old shares.
The initial number of strategic placement shares issued in this issuance was 5.7642 million shares, accounting for 15.00% of the total number of this issuance. The subscription funds promised by the strategic investors have been remitted to the bank account designated by the sponsor (lead underwriter) within the specified time. The final strategic placement of this issuance is 5152721 shares, accounting for 13.41% of the total number of this issuance. The difference between the initial strategic placement and the final strategic placement of 611479 shares is transferred back to the offline issuance.
After the strategic placement callback and before the online and offline callback mechanism was launched, the number of offline issued shares was 23476279, accounting for 70.55% of the number issued after deducting the final strategic placement; The number of shares issued online was 9799000, accounting for 29.45% of the number issued after deducting the final strategic placement. The total number of final offline and online issuance is the total number of this issuance minus the final strategic placement, with a total of 33275279 shares.
According to the callback mechanism announced in the announcement of Beijing chunlizhengda medical device Co., Ltd. on initial public offering and listing on the science and innovation board, the initial effective subscription multiple of this online offering is 4973.73 times, more than 100 times, The issuer and the recommendation institution (lead underwriter) decide to start the callback mechanism to adjust the scale of offline and online issuance, and will deduct 10% of the number of shares issued this time after the final strategic placement (rounded up to an integral multiple of 500 shares, i.e. 3328000 shares) will be transferred from offline to online. After the callback mechanism is started, the final number of shares issued offline will be 20148279 shares, accounting for 60.55% of the number issued after deducting the final strategic placement, and the final number of shares issued online will be 13127000 shares, accounting for 39.45% of the number issued after deducting the final strategic placement. After the callback mechanism is started, The final winning rate of online issuance was 0.02693401%.
The online and offline subscription and payment of this offering has been completed on December 23, 2021 (T + 2). I. statistics of new share subscription
The sponsor (lead underwriter) made statistics on the subscription of new shares issued online and offline in this strategic placement according to the payment of strategic investors and the data provided by Shanghai Stock Exchange and China Clearing Shanghai Branch. The results are as follows:
1. Strategic placement
The strategic placement of this offering includes the following two categories: (1) the relevant subsidiary of the sponsor follows the investment, and the follow-up investment institution is Huatai Innovation Investment Co., Ltd. (hereinafter referred to as "Huatai innovation"); (2) The special asset management plan established by the issuer's senior managers and core employees to participate in this strategic placement is the employee stock ownership collective asset management plan of Huatai Chunli medical home No. 1 science and Innovation Board (hereinafter referred to as "home No. 1"), and the manager is Huatai Securities Co.Ltd(601688) (Shanghai) Asset Management Co., Ltd. except for the above two categories, there are no other strategic investors. As of December 16, 2021 (T-3), all strategic investors have paid the subscription funds and the corresponding new share placement brokerage commission in full and on time (Huatai innovation does not need to pay the new share placement brokerage commission). The recommendation institution (lead underwriter) will be on December 27, 2021 Before (T + 4 day), the excess payment will be returned according to the original path.
To sum up, the final strategic placement results of this offering are as follows:
Allotment amount allotment of new shares full name of investor after the sales restriction period allotment amount (shares) (yuan, excluding Commission) Commission (month) (yuan)
Huatai Innovation Investment Co., Ltd. 153712045821547.20024
Huatai Chunli medical home No. 1 Kechuang
The total amount of collective asset management of employee stock ownership on the board is 3615601107781065.81538905.3312
Row
Total 5152721153602613.01538905.33-
2. Online subscription of new shares
(1) Number of shares subscribed by online investors (shares): 13058616
(2) Subscription amount paid by online investors (yuan): 389277342.96
(3) Number of online investors giving up subscription (shares): 68384
(4) Subscription amount abandoned by online investors (yuan): 2038527.04
3. Offline subscription of new shares
(1) Number of shares subscribed by offline investors (shares): 20148279
(2) Subscription amount paid by offline investors (yuan): 600620196.99
(3) Brokerage commission for placement of new shares paid by offline investors (yuan): 3003103.23
(4) Number of offline investors giving up subscription (shares): 0
(5) Subscription amount abandoned by offline investors (yuan): 0 2. Lottery results of online lower limit sales account
According to the announcement on the initial public offering arrangement and preliminary inquiry of Beijing chunlizhengda medical device Co., Ltd. and the announcement on the initial public offering of Beijing chunlizhengda medical device Co., Ltd. and its listing on the science and innovation board, The issuer and the recommendation institution (lead underwriter) on December 24, 2021 On the morning of (T + 3), a lottery ceremony was held at Haitang hall, the conference room on the fourth floor of Zijinshan Hotel, No. 778 Dongfang Road, Pudong New Area, Shanghai. The lottery ceremony was conducted in accordance with the principles of openness, fairness and impartiality. The lottery process and results have been notarized by Shanghai Dongfang notary office. The winning results are as follows:
Last digit winning lot number
Last "1" digit 2
Securities investment funds and other partial stock asset management products established by participating in the offline issuance, subscription and allocation of A-share shares of Chunli medical, national social security fund, basic endowment insurance fund, enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund If the mantissa of the subscription allotment number held by the placement objects such as insurance funds and QFII funds that meet the relevant provisions of the measures for the administration of the use of insurance funds is the same as the above number, it is the winning number. A total of 3757 accounts participated in offline placing and lottery in this issuance, 10% of the final allocated account (rounded up) the corresponding number of accounts is 376. According to the lottery results, the restricted period for all the winning accounts to obtain the shares for this placement is 6 months. The number of shares corresponding to this part of accounts is 1429779 shares, accounting for 7.10% of the total offline issuance and 4.30% of the total public issuance after deducting the strategic placement. The placing objects of this offline lottery are Please refer to the "attached table: details of lottery winning placement under Chunli medical network". 3、 Underwriting by the sponsor (lead underwriter)
The number of shares abandoned by online and offline investors is underwritten by the sponsor (lead underwriter). The number of shares underwritten by the sponsor (lead underwriter) is 68384 shares, and the underwriting amount is 2038527.04 yuan. The proportion of the number of underwritten shares in the number of issued shares after deducting the final strategic placement is 0.2055%, and the proportion of the number of underwritten shares in the total number of issued shares is 0.1780%.
On December 27, 2021 (T + 4), the recommendation institution (lead underwriter) will act in accordance with the recommendation agreement and the underwriting agreement The remaining stock underwriting funds, strategic placement and the funds raised from offline and online issuance will be transferred to the issuer together after deducting the recommendation and underwriting fee and the brokerage commission for new share placement. The issuer will submit an application for share registration to CSDCC Shanghai branch and register the underwritten shares in the securities account designated by the sponsor (lead underwriter). IV. contact information of the sponsor (lead underwriter)
If investors have any questions about the issuance results announced in this announcement, please contact the sponsor (lead underwriter) of this issuance. The specific contact information is as follows:
Contact: stock capital market department
Tel.: 010-56839453
Contact address: 6 / F, tower a, Fengming international building, No. 22 Fengsheng Hutong, Xicheng District, Beijing
Issuer: Beijing Chunli Zhengda medical device Co., Ltd. sponsor (lead underwriter): Huatai United Securities Co., Ltd. December 27, 2021
Attached table: placement details of winning lottery under Chunli medical network
Serial number investor name placing object name placing object code number of final placing restricted periods (shares)
1 Tongtai Fund Management Co., Ltd. Tongtai Huili hybrid securities investment fund d89020088919906 months
2 Minsheng Jiayin Fund Management Co., Ltd. Minsheng Jiayin core driven hybrid securities investment fund d89027361240526 months
Minsheng Jiayin Fund Management Co., Ltd. Minsheng Jiayin Xinfu flexible allocation of hybrid securities investment d8900577336616 month 3-month fund
Minsheng plus silver fund management Co., Ltd. Minsheng plus silver new kinetic energy regularly opens a mixed certificate d89022911840526 month 4-bond investment fund in one year
GF Fund Management Co., Ltd. GF Hengyang one-year holding hybrid securities investment fund d89029985440526 months 5 gold
GF Fund Management Co., Ltd. GF Hengchang one-year holding hybrid securities investment fund d89028571640526 months
7 GF Ruixin hybrid securities investment fund d89026498040526 months of GF Fund Management Co., Ltd
8 GF Fund Management Co., Ltd. GF balanced preferred hybrid securities investment fund d89025604240526 months
9 GF medical health hybrid securities investment fund d89024251440526 months of GF Fund Management Co., Ltd
10 GF Fund Management Co., Ltd. GF value advantage hybrid securities investment fund d8902100124526 months
11 GF Fund Management Co., Ltd. GF consumption upgrading stock securities investment fund d89017402031276 months
12 GF Fund Management Co., Ltd. GF Xinhe flexible configuration hybrid securities investment fund d89011065240526 months
GF Fund Management Co., Ltd. GF China Securities environmental protection industry trading open index certificate d89006864540526 months
